Documentos para Download:

• PDF Protocolo para Elaboração de Laudo Médico Pericial – Perícia Administrativa
• PDF Protocolo para elaboração de Laudo Médico Pericial na área securitária
• PDF Protocolo para elaboração de Laudo Médico Pericial Previdenciário no requerimento de Benefício por Incapacidade
• PDF Diretrizes para se verificar a presença de NEXO CAUSAL em Perícias Médicas junto à Justiça do Trabalho
• PDF Protocolo para Elaboração Laudo Médico Pericial na Justiça do Trabalho
• PDF Protocolo para a elaboração de Laudo Médico Pericial Cível
• PDF Protocolo para a elaboração de Laudo Médico Pericial Criminal
• PDF Diretriz para avaliação do Dano Pessoal - ABMLPM
• DIR Child abuse and neglect
• DIR Child abuse and neglect
• DIR Domestic violence and abuse
• DIR Domestic violence and abuse: multi-agency working (PH50)
• DIR Preventing Violence, Harassment and Bullying Against Health Workers, Second Edition
• DIR Violence and aggression: short-term management in mental health, health and community settings

Documentos para Download:

• PDF Câncer de colo de útero estadiamento e reestadiamento com PET/CT com FDG-18F
• PDF Câncer de Ovário Recidivado Diagnóstico por PET-CT com FDG-18F
• PDF Câncer de próstata – terapia com rádio-223
• DIR European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
• DIR INDICATIONS AND RECOMMENDATIONS FOR THE USE OF PET-CT IN THE PLANNING OF RADIATION ONCOLOGY TREATMENT. Systematic review
• DIR PET-CT — Estadiamento clínico do câncer de pulmão de células não pequenas potencialmente ressecável
• DIR Radionuclide Therapy for Neuroendocrine Malignancies C50-01

Documentos para Download:

• DIR AAOS Appropriate Use Criteria Anterior Cruciate Ligament Injuries: Prevention Programs
• DIR Ácido fólico 400 mcg + acetato de dextroalfatocoferol 10 mg — Prevenção de distúrbios do tubo neural relacionados a deficiência de ácido fólico, para mulheres em idade fértil
• DIR Alcohol-use disorders - preventing harmful drinking (PH24)
• DIR Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence
• DIR Alcohol-use disorders: diagnosis and management
• DIR Alcohol-use disorders: diagnosis and management of physical complications
• DIR Alcohol-use disorders: physical complications (CG100)
• DIR Alcohol: preventing harmful use in the community
• DIR Alcohol interventions in secondary and further education
• DIR Antisocial personality disorder: prevention and management
• DIR Appropriate Use Criteria: Anterior Cruciate Ligament Injuries: Prevention Programs
• DIR Carbetocina — Prevenção de hemorragia pós-parto
• DIR Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges
• DIR DESIGN AND VALIDATION OF A SCREENING TOOL FOR EVALUATING THE HEALTH IMPACT OF REGIONAL POLICIES
• DIR Drug misuse prevention
• DIR Drug misuse prevention: targeted interventions
• DIR EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis
• DIR EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy
• DIR Evidence-based recommendations for fall prevention
• DIR Fetal alcohol spectrum disorder
• DIR Guidelines for the validation and application of typing methods for use in bacterial epidemiology
• DIR HEALTH PROMOTION. SOME THEORIES AND TOOLS FOR PLANNING AND ASSESSING LIFESTYLE INTERVENTIONS
• DIR Hypothermia: prevention and management in adults having surgery
• DIR Integrating Tobacco Interventions into Daily Practice, Third Edition
• DIR Materiais especiais (almofada de assento com células de ar interconectadas) — Utilizada no assento da cadeira de rodas para prevenção de úlceras de pressão de usuários com alteração da mobilidade e sensibilidade
• DIR Materiais especiais (almofada de assento para cadeira de rodas para a prevenção de úlceras de pressão/simples) — Utilizada no assento da cadeira de rodas para prevenção de úlceras de pressão de usuários com alteração da mobilidade e sensibilidade
• DIR Oral health promotion: general dental practice
• DIR Oral health promotion in the community
• DIR Pain: Prevention, assessment and management, Fourth edition
• DIR Pelvic floor dysfunction: prevention and non-surgical management
• DIR Pressure injury management: Risk assessment, prevention and treatment
• DIR Prevention of preterm birth in women at risk: selected topics
• DIR Recommandations sur le dépistage du retard de développement
• DIR Recommandations sur les interventions comportementales de prévention et de traitement du tabagisme chez les enfants et adolescents d’âge scolaire
• DIR Screening Pelvic Examination in Adult Women: A Clinical Practice Guideline From the American College of Physicians
• DIR Smoking: reducing and preventing tobacco use
• DIR Smoking Cessation Interventions and Strategies (Best Practice 5(3))
• DIR Smoking cessation interventions and strategies (Best Practice 12(8))
• DIR Stop smoking
• DIR Systematic Review and Evidence-Based Guidelines Update for the Role of Audiologic Screening in the Diagnosis and Management of Patients with Vestibular Schwannomas
• DIR The Prevention and Management of Complications associated with PEG Tubes in Adults (Best Practice 14(10))
• DIR Tobacco: preventing uptake, promoting quitting and treating dependence
• DIR Tobacco: treating dependence
• DIR ​Tobacco dependency
• DIR Total fat intake for the prevention of unhealthy weight gain in adults and children
• DIR Treatment of Tobacco Use Disorder
• DIR Unintentional injuries: prevention strategies for under 15s (PH29)
• DIR WHO clinical treatment guideline for tobacco cessation in adults
• DIR WHO Guideline on the prevention of drowning through provision of day-care and basic swimming and water safety skills
• DIR WHO guideline on the prevention of female genital mutilation and clinical management of complications
• DIR WHO recommendation on routes of oxytocin administration for the prevention of postpartum haemorrhage after vaginal birth
• DIR Woman Abuse: Screening, Identification and Initial Response

Documentos para Download:

• DIR Acute kidney injury
• DIR Acute kidney injury: prevention, detection and management
• DIR Aminoácidos + análogos associados à dieta muito restritiva em proteínas — Adultos com doença renal crônica em estágios 4 ou 5 pré-dialítico
• DIR Cabozantinibe — Primeira linha de câncer renal avançado
• DIR calcitriol 1,0 mcg/mL injetável — Distúrbio Mineral Ósseo na Doença Renal Crônica
• DIR Chronic Kidney Disease (CKD). Evidence Based Nutrition Practice Guideline
• DIR Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia (CG157)
• DIR Chronic kidney disease: assessment and management
• DIR Chronic kidney disease early detection
• DIR Chronic kidney disease in adults
• DIR Ciclossilicato de zircônio sódico — Hiperpotassemia em pacientes com doença renal crônica estágios 4 e 5
• DIR Cinacalcete — Hiperparatireoidismo secundário à doença renal, em diálise e refratários à terapia convencional
• DIR Cinacalcete — Tratamento de pacientes com hiperparatireoidismo secundário à doença renal crônica estágio 5D
• DIR Clinical effectiveness of different approaches to peritoneal dialysis catheter exit-site care (Best Practice 8(1))
• DIR Cloridrato de cinacalcete — Pacientes com hiperparatireoidismo secundário (HPTS) à doença renal crônica
• DIR Cloridrato de paricalcitol — Pacientes com hiperparatireoidismo secundário (HPTS) à doença renal crônica
• DIR Dapagliflozina — Tratamento de pacientes adultos com doença renal crônica em uso de terapia padrão
• DIR Dietary and Pharmacologic Management to Prevent Recurrent Nephrolithiasis in Adults: A Clinical Practice Guideline From the American College of Physicians
• DIR Distúrbio Mineral Ósseo na Doença Renal Crônica
• DIR Effectiveness of Different Types of Care for the Peritoneal Dialysis Catheter Exit Site (Best Practice 18(9))
• DIR Estratégias para Atenuar a Progressão da Doença Renal Crônica
• DIR Guía de práctica clínica sobre la detección y el manejo de la Enfermedad Renal Crónica
• DIR Hidróxido de alumínio 300 mg ou 61,5 mg/mL — Doença renal em estágio final; Distúrbios do metabolismo do fósforo
• DIR Hidróxido de alumínio e alfacalcidol — Distúrbio Mineral Ósseo na Doença Renal Crônica e Hipoparatireoidismo
• DIR Imunoglobulina humana pó liofilizado para solução injetável ou solução injetável na concentração de 3 g ou 6 g — Imunossupressão em transplante renal
• DIR Imunossupressão no Transplante Renal
• DIR Management of Chronic Kidney Disease in Adults (Second Edition)
• DIR Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline
• DIR Micofenolato de mofetila — Nefrite lúpica
• DIR Micofenolato de mofetila — Síndrome nefrótica primária em crianças e adolescentes
• DIR Micofenolato de sódio — Síndrome nefrótica primária em crianças e adolescentes
• DIR Muromonabe — Imunossupressão em transplante renal
• DIR Paricalcitol — Tratamento de pacientes com hiperparatireoidismo secundário à doença renal crônica estágio 5D
• DIR Pesquisa de fração c4d e imunoglobulina — Rejeição aguda mediada por anticorpos no transplante renal
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Distúrbio Mineral Ósseo na Doença Renal Crônica
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Estratégias para Atenuar a Progressão da Doença Renal Crônica
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Imunossupressão em Transplante Renal
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Síndrome Nefrótica Primária em Adultos
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Síndrome Nefrótica Primária em Crianças e Adolescentes
• DIR Renal and ureteric stones
• DIR Renal and ureteric stones: assessment and management
• DIR Renal cancer in adults: diagnosis, treatment and follow-up
• DIR Renal cell carcinoma
• DIR Renal cell carcinoma nutrition
• DIR Renal replacement therapy and conservative management
• DIR Renal replacement therapy services for adults
• DIR Rituximabe — Crianças e adolescentes com síndrome nefrótica primária corticodependente e recaída frequente
• DIR Self-management of Hemodialysis for End Stage Renal Disease (Best Practice 15(8))
• DIR Sevelâmer — Tratamento da hiperfosfatemia em pacientes com doença renal crônica estágio 5D
• DIR Síndrome Nefrótica Primária em Adultos
• DIR Síndrome Nefrótica Primária em Crianças e Adolescentes
• DIR Tacrolimo — Síndrome nefrótica primária
• DIR Tacrolimo de liberação prolongada — Profilaxia de rejeição de transplante renal
• DIR The Assessment and Management of Chronic Kidney Disease in Adults

Documentos para Download:

• PDF Malformação de chiari tipo i – efeito da secção do filum terminale
• PDF Hérnia de disco lombar – tratamento com discectomia endoscopica
• PDF Cirurgias de coluna – uso da vancomicina em pó no sítio cirúrgico como profilaxia da infecção pós operatória
• PDF Neurocirurgia – uso da neuronavegação
• PDF Estimulação cerebral profunda – epilepsia
• PDF Estimulação cerebral profunda – depressão e no transtorno obsessivo compulsivo
• PDF Estimulação cerebral profunda – sintomas motores da doença de parkinson e tremor não parkinsoniano
• PDF Doença degenerativa cervical – tratamento com artroplastia cervical, discectomia cervical anterior e artrodese
• PDF Depressão – tratamento pela estimulação do nervo vago
• PDF Hérnia de Disco Lombar - Tratamento com Discectomia Endoscópica
• PDF Hérnia de Disco Lombar - Tratamento com Hidrodiscectomia Percutânea
• DIR Brain tumours, National consensus-based nutrition guideline
• DIR Early Management of Head Injury in Adults
• DIR Head injury
• DIR Head injury: assessment and early management

Documentos para Download:

• PDF Neuropatias – síndrome de guillain – barré: tratamento
• PDF Ler-dort em mmss: reabilitação

Documentos para Download:

• DIR Acetato de Glatirâmer 40mg — Esclerose múltipla remitente recorrente
• DIR Acute stroke treatment in Europe: a questionnaire-based survey on behalf of the EFNS Task Force on acute neurological stroke care
• DIR A European Academy of Neurology guideline on medical management issues in dementia
• DIR Alentuzumabe — Esclerose múltipla remitente recorrente após falha terapêutica a duas ou mais terapias
• DIR Alentuzumabe — Esclerose múltipla remitente recorrente com características comparáveis aos critérios de tratamento com natalizumabe.
• DIR Alentuzumabe — Tratamento da esclerose múltipla remitente recorrente após falha terapêutica com betainterferona ou glatirâmer
• DIR Assessment and Management of Dysphagia in Children with Neurological Impairments (Best Practice 13(1))
• DIR Australian and New Zealand Living Clinical Guidelines for Stroke Management 
• DIR Australian Motor Neurone Disease (MND) Guideline
• DIR Betainterferonas — Esclerose múltipla remitente-recorrente (EMRR)
• DIR Canabidiol — Crianças e adolescentes com epilepsias refratárias aos tratamentos convencionais
• DIR Cladribina oral — Esclerose múltipla remitente-recorrente altamente ativa.
• DIR Cladribina oral — Tratamento de pacientes com esclerose múltipla remitente-recorrente altamente ativa
• DIR Clinical Medication Guidelines for Geriatric Peripheral Neuropathic Pain
• DIR Clinical Practice Guideline for the Management of Cerebral Small Vessel Disease
• DIR Clinical practice guideline for the Management of Patients with Parkinson´s Disease
• DIR Clinical Practice Guideline for the Prevention and/or Treatment of Chemotherapy-Induced Peripheral Neuropathy using Natural Health Products
• DIR Clinical practice guidelines for surgery in patients with tuberous sclerosis complex-related epilepsy
• DIR Clinical Practice Guidelines for The Diagnosis and Treatment of Diffuse Glioma-Related Epilepsy: 2025 update
• DIR Cloridrato de fingolimode — Primeira linha de pacientes com esclerose múltipla remitente recorrente, de baixa e moderada atividade, em troca entre os medicamentos de primeira linha ou virgens de tratamento
• DIR Cloridrato de memantina — Alzheimer moderada e grave em pacientes com disfagia
• DIR Clozapina — Psicose associada à doença de Parkinson
• DIR Composto nutricional — Melhora de memória em pacientes com doença de Alzheimer na fase leve
• DIR DESIGN OF AN INTERACTION PROTOCOL BETWEEN PRIMARY CARE AND HOSPITALS TO IMPROVE EARLY DETECTION AND MONITORING OF PATIENTS WITH MULTIPLE SCLEROSIS
• DIR Diagnosis and drugs consumption for Alzheimer's disease in the Basque Country
• DIR Diagnosis and management of epilepsy in adults (SIGN CPG 143)
• DIR Dicloridrato de pramipexol — Liberação prolongada para parkinson idiopática em fase inicial ou avançada
• DIR Doença de Alzheimer
• DIR Doença de Parkinson
• DIR Donepezila — Pacientes com doença de Alzheimer grave
• DIR Duloxetina — Dor neuropática e da fibromialgia
• DIR EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke
• DIR EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke
• DIR EAN guideline on palliative care of people with severe, progressive multiple sclerosis
• DIR EAN guideline on palliative care of people with severe, progressive multiple sclerosis
• DIR EAN guideline on palliative care of people with severe, progressive multiple sclerosis
• DIR EAN guidelines on central neurostimulation therapy in chronic pain conditions
• DIR ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
• DIR ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
• DIR EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease
• DIR EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease
• DIR EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force
• DIR EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force
• DIR EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force
• DIR EFNS guideline on the management of status epilepticus
• DIR EFNS guideline on the management of status epilepticus in adults
• DIR EFNS guideline on the treatment of tension-type headache – Report of an EFNS task force
• DIR EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses
• DIR EFNS guidelines for the diagnosis and management of Alzheimer’s disease
• DIR EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases
• DIR EFNS guidelines on management of narcolepsy
• DIR EFNS guidelines on neuropathic pain assessment: revised 2009
• DIR EFNS guidelines on neurostimulation therapy for neuropathic pain
• DIR EFNS guidelines on pharmacological treatment of neuropathic pain
• DIR EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force
• DIR EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias
• DIR EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington’s disease, Parkinson’s disease and dystonias
• DIR EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
• DIR EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis
• DIR EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy
• DIR EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy
• DIR EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives
• DIR EFNS task force on molecular diagnosis of neurologic disorders Guidelines for the molecular diagnosis of inherited neurologic diseases First of two parts
• DIR EFNS task force on molecular diagnosis of neurologic disorders Guidelines for the molecular diagnosis of inherited neurologic diseases Second of two parts
• DIR EFNS Task Force on postgraduate neurological training Survey of the current situation of postgraduate neurological training in Europe
• DIR EFNS Task Force on Teaching of Neuroimaging in Neurology Curricula in Europe: present status and recommendations for the future
• DIR Epilepsia
• DIR Epilepsies in children, young people and adults
• DIR Epilepsies in children, young people and adults
• DIR Epilepsies in children and young people: Investigative procedures and management (SIGN CPG 159)
• DIR Esclerose Múltipla
• DIR Estimulação elétrica do nervo vago — Terapia adjuvante de pacientes pediátricos com epilepsia resistente a medicamentos, sem indicação para cirurgia ressectiva de epilepsia
• DIR Estimulação elétrica do nervo vago na terapia adjuvante — Farmacológico em crianças e adultos com epilepsia focal ou generalizada refratária a pelo menos dois esquemas com medicamentos anticonvulsivantes para epilepsia
• DIR European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO‐NMD)
• DIR European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies
• DIR European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision
• DIR European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome
• DIR European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome
• DIR European Academy of Neurology and European Federation of Neurorehabilitation Societies guideline on pharmacological support in early motor rehabilitation after acute ischaemic stroke
• DIR European Academy of Neurology guideline on the diagnosis of coma and other disorders of consciousness
• DIR European Academy of Neurology guideline on the management of medication-overuse headache
• DIR European Academy of Neurology guideline on trigeminal neuralgia
• DIR European Academy of Neurology guidelines on the treatment of cluster headache
• DIR European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher
• DIR European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher
• DIR European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy*
• DIR European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Socie
• DIR European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Ne
• DIR European guideline and expert statements on the management of narcolepsy in adults and children
• DIR European guideline and expert statements on the management of narcolepsy in adults and children
• DIR European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society
• DIR European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment
• DIR Fingolimode — Esclerose múltipla
• DIR Fingolimode — Esclerose múltipla
• DIR Fingolimode — Esclerose múltipla remitente recorrente após falha terapêutica com betainterferona ou glatirâmer
• DIR Fumarato de dimetila — Esclerose múltipla remitente-recorrente após a 1ª falha terapêutica
• DIR Fumarato de dimetila — Esclerose múltipla remitente recorrente após falha com betainterferona ou glatirâmer
• DIR Fumarato de dimetila — Primeira linha da esclerose múltipla remitente recorrente
• DIR Guidance for the preparation of neurological management guidelines by EFNS scientific task forces
• DIR Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004*
• DIR Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2012
• DIR Guidelines by the European Federation of Neurological Societies (EFNS) subcommittee for Continuing Medical Education (CME) – modification 2003
• DIR Guidelines for Specialized Epilepsy Centers. Executive Summary of the Report of the National Association of Epilepsy Centers Guideline Panel
• DIR Guidelines on use of anti-IFN-B antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-B antibodies in multiple sclerosis
• DIR Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-β antibodies in multiple sclerosis
• DIR ​Headache in adult
• DIR Headaches in over 12s
• DIR Headaches in over 12s: diagnosis and management
• DIR Identification and Management of Dysphagia in Children with Neurological Impairment (Best Practice 4(3))
• DIR Joint European Academy of Neurology–European Pain Federation–Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment
• DIR KNGF Guideline for Physical Therapy in patients with Parkinson's disease
• DIR Lacosamida — Terapia aditiva em pacientes com epilepsia focal refratários aos tratamentos prévios com os fármacos antiepilépticos disponíveis no SUS
• DIR Levetiracetam (500 mg e 1000 mg) — Tratamento adjuvante para epilepsia
• DIR Levetiracetam — Convulsões em pacientes com microcefalia
• DIR Levetiracetam — Epilepsia
• DIR Levetiracetam — Terapia adjuvante em pacientes com epilepsia mioclônica juvenil resistentes à monoterapia
• DIR Levetiracetam em monoterapia — Epilepsia focal em pacientes com falha no tratamento com carbamazepina
• DIR Lidocaína — Dor neuropática localizada
• DIR Management of Ischaemic Stroke (2nd Edition)
• DIR Management of Multiple Sclerosis
• DIR Management of paraneoplastic neurological syndromes: report of an EFNS Task Force
• DIR Memantina — Doença de Alzheimer
• DIR Mesilato de bromocriptina — Doença de Parkinson e de hiperprolactinemia.
• DIR Mesilato de rasagilina em combinação com levodopa — Doença de Parkinson com complicações motoras
• DIR Miglustate — Manifestações Neurológicas da Doença de Niemann-Pick Tipo C (NPC)
• DIR Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas: Guideline From the College of American Pathologists in Collaboration With the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology
• DIR Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology
• DIR Monogenic cerebral small‐vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology
• DIR Motor neurone disease
• DIR Motor neurone disease: assessment and management
• DIR Multiple sclerosis
• DIR Multiple sclerosis in adults: management
• DIR Natalizumabe — Esclerose múltipla remitente-recorrente com alta atividade de doença
• DIR Natalizumabe 300mg — Esclerose múltipla
• DIR National clinical guideline for stroke for the UK and Ireland (SIGN CPG 166)
• DIR Neuropathic pain in adults: pharmacological management in non-specialist settings
• DIR Neurophysiological tests and neuroimaging procedures in non-acute headache: guidelines and recommendations
• DIR Ocrelizumabe — Adultos com esclerose múltipla remitente-recorrente (EMRR) como alternativa ou contraindicação ao natalizumabe
• DIR Ocrelizumabe — Esclerose Múltipla primariamente
• DIR Ocrelizumabe — Recorrencia de Esclerose Múltipla
• DIR Ofatumumabe em primeira linha de terapia modificadora do curso da doença — Tratamento da esclerose múltipla recorrente
• DIR Parkinson's disease
• DIR Parkinson's disease in adults
• DIR PET Imaging in Paraneoplastic Neurological Syndromes 18
• DIR Pharmacological management of migraine (SIGN CPG 155)
• DIR Pharmacological treatment of migraines. Qualitative study
• DIR Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians
• DIR Pregabalina — Dor neuropática e fibromialgia
• DIR Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
• DIR Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Doença de Alzheimer
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Doença de Alzheimer
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Doença de Parkinson
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Doença de Parkinson
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Epilepsia
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Esclerose Múltipla
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Esclerose Múltipla
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Esclerose Múltipla
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Esclerose Múltipla
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Esclerose Múltipla
• DIR QUALITY OF LIFE OF STROKE PATIENTS AND THEIR CAREGIVERS. PROGNOSIS AND RESULTS OF REHABILITATING TREATMENT
• DIR Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
• DIR Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke)
• DIR Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's dise
• DIR Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease
• DIR Rivastigmina — Doença de Parkinson e demência
• DIR Rivastigmina adesivo transdérmico — Demência para Doença de Alzheimer
• DIR Rivastigmina via transdérmica (adesivo) — Demência leve e moderadamente grave do tipo Alzheimer
• DIR Selegilina — Doença de Parkinson
• DIR Selegilina 10 mg — Doença de Parkinson
• DIR Stroke and transient ischaemic attack in over 16s: diagnosis and initial management
• DIR Stroke in adults
• DIR Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease
• DIR Suspected neurological conditions: recognition and referral
• DIR Suspected neurological conditions: recognition and referral
• DIR Systematic Review and Evidence-Based Guidelines for Occipital Nerve Stimulation for the Treatment of Patients With Medically Refractory Occipital Neuralgia Update
• DIR Teriflunomida — Primeira linha de tratamento da esclerose múltipla remitente recorrente
• DIR The Diagnosis & Management of Stroke and Transient Ischaemic Attack
• DIR The Utility of Positron Emission Tomography in Epilepsy 13
• DIR Tolcapona 100 mg — Doença de Parkinson
• DIR Traditional Chinese Medicine treatment guideline for primary headache disorders(NGC: 011363)
• DIR Treatment of medication overuse headache – guideline of the EFNS headache panel
• DIR Treatment of miscellaneous idiopathic headache disorders (group 4 of the IHS classification) – Report of an EFNS task force
• DIR When to order CT/MRI for headache

Documentos para Download:

• PDF Avaliação da Composição Corporal por Bioimpedanciometria
• PDF Avaliação nutrológica – nutroterapia intrahospitalar
• PDF Avaliação nutrológica – monitorização da composição corporal
• PDF Avaliação nutrológica – monitorização ambulatorial da mobilidade (mam)
• PDF Avaliação nutrológica – ergometria modal
• PDF Dismenorreia primária tratamento
• DIR Academy of Nutrition and Dietetics Evidence Analysis Manual
• DIR Adult Weight Management (AWM). Evidence Based Nutrition Practice Guideline
• DIR Alimento para nutrição enteral ou oral — Nutrição enteral ou oral no pré-operatório de cirurgias oncológicas gastrointestinais eletivas de grande porte
• DIR Australian Dietary Guidelines (2013) (N 55)
• DIR Bladder cancer. National consensus-based nutrition guideline
• DIR Congress of Neurological Surgeons Systematic Review and Evidence-based Guidelines for Perioperative Spine: Preoperative Nutritional Assessment
• DIR Critical Illness. Evidence-Based Nutrition Practice Guideline
• DIR Effective dietary interventions for overweight and obese children (Best Practice 11(1))
• DIR Esophagus cancer nutrition
• DIR Food and Nutrition for Older Adults Promoting Health and Wellness Recommendations (FNOA)
• DIR General Nutrition and Dietary treatment
• DIR Guideline: fortification of wheat flour with vitamins and minerals as a public health strategy
• DIR Lung cancer. National consensus-based nutrition guideline
• DIR Maternal and child nutrition (PH11)
• DIR Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years
• DIR Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years (NG247)
• DIR Neonatal parenteral nutrition
• DIR Neonatal parenteral nutrition
• DIR Nutrition and dietary therapy for lungcancer (english version). National nutrition consensus guideline
• DIR Nutrition in patients with gastric cancer
• DIR Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition
• DIR Nutrition support in adults
• DIR Oncology (ONC). Evidence-based Nutrition Practice Guideline
• DIR Oral liquid nutritional supplements for people with dementia in residential aged care facilities (Best Practice 14(3))
• DIR Pancreatic cancer nutrition
• DIR Pediatric Weight Management (PWM). Evidence-Based Nutrition Practice Guideline
• DIR Prostatic cancer nutrition
• DIR Suplementação nutricional oral — Clínicos ou cirúrgicos desnutridos ou em risco de desnutrição
• DIR The Recognition, Prevention and Management of Vitamin D Deficiency in Children and Adults
• DIR Unintended Weight Loss (UWL) in Older Adults. Evidence-based Nutrition Practice Guideline
• DIR VALIDATION OF A MALNUTRITION SCREENING TOOL USEFUL IN A GENERAL HOSPITAL
• DIR Vegetarian Nutrition (VN). Evidence-Based Nutrition Practice Guideline
• DIR Vitamin B12 deficiency in over 16s: diagnosis and management
• DIR Vitamin D: supplement use in specific population groups (PH56)
• DIR WHO guideline on the dairy protein content in ready-to-use therapeutic foods for treatment of uncomplicated severe acute malnutrition
• DIR WHO guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years

Documentos para Download:

• PDF Astigmatismo - Lentes De Contato Descartáveis
• PDF Miopia - Lentes De Contato Descartáveis
• PDF Presbiopia - Lentes De Contato Descartáveis
• DIR Aflibercepte e ranibizumabe — Degeneração Macular Relacionada à Idade (DMRI) neovascular em pacientes acima de 60 anos
• DIR Age-related macular degeneration
• DIR Cataracts in adults: management
• DIR Degeneração Macular Relacionada com a Idade - Portaria Conjunta nº 24
• DIR Dépistage de la déficience visuelle en médecine de soins primaires chez les adultes de 65 ans et plus vivant dans la collectivité
• DIR Exame de Tomografia de Coerência Óptica — Confirmação diagnóstica de glaucoma
• DIR Glaucoma
• DIR Glaucoma: diagnosis and management
• DIR Glaucoma referral and safe discharge (SIGN CPG 144)
• DIR Implante de drenagem oftalmológico — Glaucoma primário de ângulo aberto leve a moderado
• DIR Management of Glaucoma (Second Edition)
• DIR Ophthalmic implants in glaucoma surgery. Safety and effectiveness analysis
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Degeneração Macular Relacionada à Idade
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Degeneração Macular Relacionada à Idade (forma neovascular)
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Degeneração Macular Relacionada com a Idade (forma neovascular)
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Glaucoma
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Glaucoma
• DIR Ranibizumabe — Degeneração macular relacionada à idade exsudativa
• DIR Retinal protection during eye surgery
• DIR Retinopathy of Prematurity
• DIR Serious eye disorders
• DIR Tomografia de coerência óptica — Avaliação de doenças da retina